ERBB2 and cancer: R-909 and R-809 failed to kill the HER2-neg MDA-MB-231 cancer cells (Fig 3E), consistent with failure to infect them, whereas the wt HSV-1(F) killed about 90% at 7 days after infection (Fig 3E).